Alector (ALEC) Other Accumulated Expenses (2018 - 2025)
Alector (ALEC) posted quarterly Other Accumulated Expenses of $495000.0 for Q4 2025, up 2.7% year-over-year from $482000.0 in Q4 2024, and up 2.7% quarter-over-quarter from $482000.0 in Q4 2024.
Alector (ALEC) Other Accumulated Expenses (2018 - 2025) Analysis & Trends
Alector (ALEC) has reported Other Accumulated Expenses for 8 consecutive years, with $495000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Accumulated Expenses rose 2.7% year-over-year to $495000.0; the TTM figure through Dec 2025 stood at $495000.0 (up 2.7% YoY), while the FY2025 annual figure was $495000.0, up 2.7% from the prior year.
- Other Accumulated Expenses advanced to $495000.0 in Q4 2025 per ALEC's latest filing, from $482000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $709000.0 in Q4 2022 and bottomed at $318000.0 in Q4 2021.
- Historically, Other Accumulated Expenses has averaged $485400.0 across 5 years, with a median of $482000.0 in 2024.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses jumped 122.96% — and 2023, when it tumbled 40.34%.
- Alector's Other Accumulated Expenses stood at $318000.0 in 2021, then soared by 122.96% to $709000.0 in 2022, then tumbled by 40.34% to $423000.0 in 2023, then gained by 13.95% to $482000.0 in 2024, then climbed by 2.7% to $495000.0 in 2025.
- Business Quant data shows ALEC's Other Accumulated Expenses at $495000.0 in Q4 2025, $482000.0 in Q4 2024, and $423000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 495,000.00 |
| Dec 31, 2024 | 482,000.00 |
| Dec 31, 2023 | 423,000.00 |
| Dec 31, 2022 | 709,000.00 |
| Dec 31, 2021 | 318,000.00 |
| Dec 31, 2020 | 353,000.00 |
| Dec 31, 2019 | 615,000.00 |
| Sep 30, 2019 | 122,000.00 |
| Jun 30, 2019 | 156,000.00 |
| Mar 31, 2019 | 165,000.00 |
| Dec 31, 2018 | 971,000.00 |